Impact of inflammatory bowel disease on quality of life, anxiety, and depression: a multicenter study in Lima, Peru
DOI:
https://doi.org/10.47892/rgp.2026.461.2125Keywords:
Inflammatory Bowel Diseases, Quality of Life, Anxiety, DepressionAbstract
Inflammatory bowel disease (IBD) is a chronic condition characterized by periods of activity and remission, with an uncertain and unpredictable course. It mainly affects the economically active population and may compromise physical, psychological, social, and occupational well-being. Objective: The aim of this study was to describe health-related quality of life and the presence of anxiety and depression in patients with IBD. Materials and methods: An observational, descriptive, cross-sectional study was conducted between April and December 2023. Patients older than 16 years with a confirmed diagnosis of IBD, at least six months of disease duration, and regular pharmacological treatment were included. The Inflammatory Bowel Disease Questionnaire-32 (IBDQ-32), the Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder-7 (GAD-7) were administered. Results: Most patients (70%) reported a high quality of life, with no significant differences between ulcerative colitis and Crohn’s disease. However, a significant reduction in health-related quality of life was observed in patients with active disease. Symptoms of depression were identified in 62.2% of patients, and anxiety in 58.1%, with both conditions being more frequent in patients younger than 30 years. Conclusions: Although most patients with IBD maintain a good quality of life, more than half experience symptoms of anxiety or depression, even during clinical remission. These findings highlight the importance of integrating mental health assessment and management as an essential component of comprehensive IBD care, in accordance with STRIDE II recommendations.
Downloads
References
Fiest K, Bernstein C, Walker J, Graff L, Hitchon C, Peschken C, et al. Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease. BMC Res Notes. 2016;9(1):404. doi: 10.1186/s13104-016-2204-2.
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, MikockaWalus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis. 2018;24(4):742-751. doi: 10.1093/ibd/izx100.
Alrubaiy L, Rikaby I, Dodds P, Hutchings HA, Williams JG. Systematic review of health-related quality of life measures for inflammatory bowel disease. J Crohns Colitis. 2015;9(3):284- 92. doi: 10.1093/ecco-jcc/jjv002.
Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, et al. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol. 2017;2017:6496727. doi: 10.1155/2017/6496727.
Hu S, Chen Y, Chen Y, Wang C. Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease. Front Psychiatry. 2021;12:714057. doi: 10.3389/fpsyt.2021.714057.
Iglesias M, Barreiro de Acosta M, Vázquez I, Figueiras A, Nieto L, Lorenzo A, et al. Psychological impact of Crohn’s disease on patients in remission: anxiety and depression risks. Rev Esp Enferm Dig. 2009;101(4):249-57.
Calvo Bernal MDM, Pérez Campos E, Aparicio Mota A, Hernández Martínez Á. Assessment of the quality of life of patients with inflammatory bowel disease. Gastroenterol Hepatol. 2025;48(1):502192. doi: 10.1016/j. gastrohep.2024.502192.
Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013;7(6):467-73. doi: 10.1016/j.crohns.2012.07.012.
López Cortés R, Marín Fernández B, Hueso Montoro C, Escalada Hernández P, Sanz Aznarez AC, Rodríguez Gutiérrez C. Calidad de vida relacionada con la salud en pacientes con enfermedad inflamatoria intestinal. An Sist Sanit Navar. 2016;39(1):123-31. doi: 10.4321/S1137-6627/2016000100014.
Parra-Izquierdo V, Frías-Ordoñez JS, Márquez JR, PuentesManosalva F, Sarmiento F, García-Duperly R, et al. Calidad de vida relacionada con la salud en pacientes con enfermedad inflamatoria intestinal. Rev Gastroenterol Peru. 2023;43(2):95-103.
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, MikockaWalus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis. 2018;24(5):966-976. doi: 10.1093/ibd/izy015.
Bernabéu Juan P, Cabezos Sirvent P, Sempere Robles L, vander Hofstadt Gomis A, Rodríguez Marín J, van-der Hofstadt Román CJ. Differences in the Quality of Life of Patients Recently Diagnosed with Crohn’s Disease and Ulcerative Colitis. Int J Environ Res Public Health. 2023;20(16):6576. doi: 10.3390/ ijerph20166576.
Mayorga A, Rodríguez V, Dávila S, Andrade D, Carrillo J, Ordóñez M, et al. Calidad de vida en pacientes con enfermedad inflamatoria intestinal. Rev Cient INSPILIP. 2019;3(2). doi: 10.31790/inspilip.v3i2.137.
Colmenárez G, Armanie E. Calidad de vida en pacientes con enfermedad inflamatoria intestinal. Hospital Central Universitario Dr. Antonio María Pineda. Bol méd postgrado. 2018;34(2):17-23.
Gili M, Bauzá N. Calidad de vida y personalidad en la enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2009;32(S2):3-8. doi: 10.1016/S0210-5705(09)72597-X.
Bisgaard TH, Allin KH, Elmahdi R, Jess T. The bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis. Gen Hosp Psychiatry. 2023;83:109-116. doi: 10.1016/j.genhosppsych.2023.05.002.
Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359- 370. doi: 10.1016/S2468-1253(21)00014-5.
Qualter P, Rouncefield-Swales A, Bray L, Blake L, Allen S, Probert C, et al. Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition. Qual Life Res. 2021;30(2):497-506. doi: 10.1007/ s11136-020-02653-9.
Dregan A, Matcham F, Harber-Aschan L, Rayner L, Brailean A, Davis K, et al. Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation. Ann Rheum Dis. 2019;78(5):688-695. doi: 10.1136/annrheumdis-2018-214676.
Barreiro-de Acosta M, Gisbert JP. Letter: psychological remission - a future endpoint in inflammatory bowel disease? Aliment Pharmacol Ther. 2014;39(12):1436. doi: 10.1111/ apt.12766.
Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Juan Eloy Paredes-Méndez, Hugo Guillermo Cedrón-Cheng, Claudia Azañedo, Rossana Andrea Franco-Vásquez, Ana Lucía Mestanza-Rivasplata, Sonia Irene Junes Pérez, Henry Vargas Marcacuzco
This work is licensed under a Creative Commons Attribution 4.0 International License.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
2022 